BNP Paribas Asset Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
BNP Paribas Asset Management's BLUE Position: Q4 2019 in Review
BNP Paribas Asset Management sold out of bluebird bio (BLUE) in Q4 2019, closing a stake of 1,593 shares — an estimated $1.9M sold.
BNP Paribas Asset Management first reported a position in BLUE in Q4 2014 and held it in 12 quarters. The position peaked at $13M in Q1 2015. 274 funds tracked by Wall St. Rank hold BLUE as of Q4 2019.
- BNP Paribas Asset Management reported no remaining bluebird bio position as of Q4 2019 after selling out during the quarter.
- BNP Paribas Asset Management sold 1,593 bluebird bio shares in Q4 2019, an estimated $1.9M.
- BNP Paribas Asset Management first reported a position in bluebird bio in Q4 2014 and held it in 12 quarters.
- BNP Paribas Asset Management's bluebird bio position peaked at $13M in Q1 2015.
- 274 funds tracked by Wall St. Rank held bluebird bio as of Q4 2019.
Based on BNP Paribas Asset Management's 13F filing for Q4 2019, filed 11 Feb 2020.